- Home
- WFC vs ABT Comparison
WFC vs ABT Comparison
Compare WFC & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFC
- ABT
- Stock Information
- Founded
- WFC 1852
- ABT 1888
- Country
- WFC United States
- ABT United States
- Employees
- WFC N/A
- ABT N/A
- Industry
- WFC Major Banks
- ABT Medical/Dental Instruments
- Sector
- WFC Finance
- ABT Health Care
- Exchange
- WFC Nasdaq
- ABT Nasdaq
- Market Cap
- WFC 261.0B
- ABT 233.7B
- IPO Year
- WFC N/A
- ABT N/A
- Fundamental
- Price
- WFC $80.67
- ABT $134.58
- Analyst Decision
- WFC Buy
- ABT Strong Buy
- Analyst Count
- WFC 15
- ABT 18
- Target Price
- WFC $84.04
- ABT $145.00
- AVG Volume (30 Days)
- WFC 14.0M
- ABT 5.9M
- Earning Date
- WFC 10-14-2025
- ABT 10-15-2025
- Dividend Yield
- WFC 2.23%
- ABT 1.75%
- EPS Growth
- WFC 19.49
- ABT 151.50
- EPS
- WFC 5.82
- ABT 7.97
- Revenue
- WFC $77,618,000,000.00
- ABT $43,109,000,000.00
- Revenue This Year
- WFC $7.81
- ABT $7.61
- Revenue Next Year
- WFC $4.68
- ABT $7.84
- P/E Ratio
- WFC $13.85
- ABT $16.88
- Revenue Growth
- WFC N/A
- ABT 5.85
- 52 Week Low
- WFC $54.41
- ABT $110.86
- 52 Week High
- WFC $86.66
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- WFC 43.33
- ABT 55.33
- Support Level
- WFC $80.04
- ABT $129.08
- Resistance Level
- WFC $85.64
- ABT $135.45
- Average True Range (ATR)
- WFC 1.74
- ABT 2.67
- MACD
- WFC -0.45
- ABT -0.14
- Stochastic Oscillator
- WFC 9.52
- ABT 65.40
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.